Literature DB >> 10426259

Sexual activity questionnaires in clinical trials: acceptability to patients with gynaecological disorders.

M L Stead1, W D Crocombe, L J Fallowfield, P Selby, T J Perren, R Garry, J M Brown.   

Abstract

OBJECTIVE: To assess the feasibility and acceptability of including sexual activity questionnaires in gynaecological clinical trials.
DESIGN: A longitudinal quality of life study during the Maintenance Interferon Trial and the EVALUATE Hysterectomy Trial.
SETTING: Gynaecology clinics and women's homes. SAMPLE: Ninety-six women with advanced ovarian cancer participating in the Maintenance Interferon Trial and 542 women undergoing a hysterectomy in the EVALUATE Hysterectomy Trial.
METHODS: Quality of life questionnaires, including the sexual activity questionnaire, were completed by women prior to randomisation and periodically after randomisation. MAIN OUTCOME MEASURES: Compliance rates of the sexual activity questionnaire, both overall and with respect to the level of sexual functioning and age of the women. Attitudes of the women towards completing the questionnaire, and suitability of using the sexual activity questionnaire in clinical trials.
RESULTS: Compliance rates of over 80% were achieved in both trials, both overall and for each questionnaire completed. The age of the woman did not appear to influence the completion of the questionnaire, nor did her level of sexual functioning. Women were supportive of the research and did not find the questionnaire intrusive.
CONCLUSIONS: It is feasible to include sexual activity questionnaires in gynaecological clinical trials requiring repeated assessment of quality of life over a long period of time. The sexual activity questionnaire is an appropriate tool to carry out investigations of sexual functioning and is worth considering for use in future clinical trials.

Entities:  

Mesh:

Year:  1999        PMID: 10426259     DOI: 10.1111/j.1471-0528.1999.tb08084.x

Source DB:  PubMed          Journal:  Br J Obstet Gynaecol        ISSN: 0306-5456


  8 in total

1.  Electronic pelvic floor symptoms assessment: tests of data quality of ePAQ-PF.

Authors:  G L Jones; S C Radley; J Lumb; S Jha
Journal:  Int Urogynecol J Pelvic Floor Dysfunct       Date:  2008-06-14

2.  The psychosocial impact of bilateral prophylactic mastectomy: prospective study using questionnaires and semistructured interviews.

Authors:  M B Hatcher; L Fallowfield; R A'Hern
Journal:  BMJ       Date:  2001-01-13

3.  Are members of multidisciplinary teams in breast cancer aware of each other's informational roles?

Authors:  V A Jenkins; L J Fallowfield; K Poole
Journal:  Qual Health Care       Date:  2001-06

4.  Enhancing the sexual function of women living with chronic pain: a cognitive-behavioural treatment group.

Authors:  A Breton; C M Miller; K Fisher
Journal:  Pain Res Manag       Date:  2008 May-Jun       Impact factor: 3.037

5.  Sexuality and body image after uterine artery embolization and hysterectomy in the treatment of uterine fibroids: a randomized comparison.

Authors:  Wouter J K Hehenkamp; Nicole A Volkers; Wouter Bartholomeus; Sjoerd de Blok; Erwin Birnie; Jim A Reekers; Willem M Ankum
Journal:  Cardiovasc Intervent Radiol       Date:  2007 Sep-Oct       Impact factor: 2.740

Review 6.  Sexual Health Screening for Gynecologic and Breast Cancer Survivors: A Review and Critical Analysis of Validated Screening Tools.

Authors:  Innes Tounkel; Shreya Nalubola; Alexandra Schulz; Nisha Lakhi
Journal:  Sex Med       Date:  2022-03-12       Impact factor: 2.523

Review 7.  Interventions for psychosexual dysfunction in women treated for gynaecological malignancy.

Authors:  Paul Flynn; Fiona Kew; Steve R Kisely
Journal:  Cochrane Database Syst Rev       Date:  2009-04-15

8.  A randomised controlled trial to assess the efficacy of Laparoscopic Uterosacral Nerve Ablation (LUNA) in the treatment of chronic pelvic pain: The trial protocol [ISRCTN41196151].

Authors: 
Journal:  BMC Womens Health       Date:  2003-12-08       Impact factor: 2.809

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.